Financial Disclosures

Celgene provides financial support to a range of organisations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact.

Payments to Patient Groups

In 2020, Celgene provided payments to, or on behalf of, the following patient groups in the UK:

ACLT – AFRICAN CARIBBEAN LEUKAEMIA TRUST

  • 2020 grant to support public awareness and education, access to education tools, design of new digital literature, supporting campaigns, increasing online engagement to escalate Black donor representation
    £15,000
  • 2019 grant towards local donor drives to recruit BME (Black Minority Ethnic) individuals to blood, bone marrow and/or organ donor registers
    £8,000

Blood Cancer Alliance

  • Grant to support BCA meetings, improve the provision and impact of blood cancer data, monitor and respond to policy environment, maintain website and raise the profile of blood cancer
    £25,000

Blood Cancer UK (formerly Bloodwise)

  • 2019 grant to support the costs of delivering Bloodwise’s Healthcare Professional Education and Engagement work
    £24,000
  • Covid Rapid Response Fund to support patient services, increase access to clinical expertise and improve technology and telephony systems
    £11,563
  • Grant to support costs of delivering Access to Clinical Trials project for year 1 of the project
    £39,000

Cancer Support Scotland

  • Grant to support the charity’s life changing services for thousands of cancer patients and their families including counselling, complimentary therapy and podiatry
    £5,000

Lymphoma Action

  • Consultancy fee towards the development of an educational video in November 2019 about the use and therapeutic potential of CAR-T cell therapies
    £400
  • Consultancy fee towards the development of an internal video in February 2020 on lymphoma
    £200
  • Grant to support information for people affected by lymphoma, education programmes, and information and support helpline
    £20,000
  • Covid Rapid Response Fund to continue to provide support and information to all those affected by lymphoma in the challenging time
    £15,000

MPN Voice (Guy’s and St Thomas’s Charity)

  • Grant towards support services for 2020 including maintaining the website, communication with patients and healthcare professionals, annual patient’s forums, advocacy, information booklets and patient surveys
    £10,000

MS Society

  • Grant towards core case for investment in MS Services feasibility study to develop a robust economic case for increased investment in MS services
    £7,166
  • Covid Rapid Response Fund to manage the pressure on service and respond to the urgent, changing needs of the MS community, ensuring that the people most in need will remain connected, safe and healthy during this time of crisis
    £20,000

MS Trust

  • Covid Rapid Response Fund to support a sustainable enhanced support service for people with MS, equip people to manage their MS symptoms and worsening quality of life and provide reliable sources of MS support
    £20,000

Myeloma UK

  • Grant to support Myeloma UK’s understanding of the support and innovations required to make a lasting change to patient experience, from HCP education, patient information, peer to peer support and the development of and access to cutting-edge treatments
    £40,000
  • Grant towards Myeloma Early Diagnosis project to improve early diagnosis of myeloma patients through GP awareness and developing an economic model
    £20,000

Pancreatic Cancer UK

  • Grant towards general mission and objectives of Pancreatic Cancer between 1 November 2020 and 30 October 2021
    £30,000

 


Financial disclosures for 2019
Financial disclosures for 2018


NO-GB-2100224
Date of preparation: June 2021